Thiomers and thiomer-based nanoparticles in protein and DNA drug delivery

Expert Opinion on Drug Delivery

Volumn 9, Issue 9, 2012, Pages 1069-1081

  Hauptstein, Sabine ^a   Bernkop Schnürch, Andreas ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

DNA drugs; Nanoparticles; Oral delivery; Protein drugs; Thiomers

Indexed keywords

2 IMINOTHIOLANE; ANTISENSE OLIGONUCLEOTIDE; CALCITONIN; CARBOXYMETHYLCELLULOSE; CHITOSAN; CHITOSAN DERIVATIVE; CYCLODEXTRIN; ENKEPHALIN; EXCIPIENT; GELATIN; GLYCOPROTEIN P; GREEN FLUORESCENT PROTEIN; HYDROGEN PEROXIDE; INSULIN; LEUPRORELIN; LIPOFECTIN; MERCAPTAMINE; NANOCARRIER; NUCLEOPHILE; PECTIN; PLASMID DNA; POLYACRYLIC ACID; POLYCARBOPHIL; RHODAMINE 123; SODIUM SULFATE; THIOGLYCOLIC ACID; THIOMER NANOPARTICLE; TRIPOLYPHOSPHATE; UNCLASSIFIED DRUG;

ANTIDIABETIC ACTIVITY; CHEMICAL BOND; CHROMATOGRAPHY; COVALENT BOND; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG DELIVERY SYSTEM; ENZYMATIC DEGRADATION; GENE DELIVERY SYSTEM; GENETIC TRANSFECTION; HUMAN; HYDROGEN BOND; IN VITRO STUDY; IN VIVO STUDY; INTESTINE MUCOSA; MUCOADHESION; NONHUMAN; OXIDATION; PROCESS OPTIMIZATION; REPORTER GENE; REVIEW; SPECTROPHOTOMETRY; TAUTOMER;

ACRYLIC RESINS; ANIMALS; BIOLOGICAL TRANSPORT; CHITOSAN; DNA; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; HUMANS; NANOPARTICLES; PEPTIDES; POLYMERS;

EID: 84865319222     PISSN: 17425247     EISSN: 17447593     Source Type: Journal    
DOI: 10.1517/17425247.2012.697893     Document Type: Review

References (87)

1. Werle M, Bernkop-Schnurch A. Thiolated chitosans: useful excipients for oral drug delivery. J Pharm Pharmacol 2008;60(3):273-81 (Pubitemid 351269813)
2. Khafagy E-S, Morishita M, Onuki Y, Takayama K. Current challenges in non-invasive insulin delivery systems: a comparative review. Adv Drug Deliv Rev 2007;59(15):1521-46 (Pubitemid 350122777)
3. Antosova Z, Mackova M, Kral V, Macek T. Therapeutic application of peptides and proteins: parenteral forever? Trends Biotechnol 2009;27(11):628-35
4. Frokjaer S, Otzen DE. Protein drug stability: a formulation challenge. Nat Rev Drug Discov 2005;4(4):298-306 (Pubitemid 41130943)
5. Emerich DF, Thanos CG. The pinpoint promise of nanoparticle-based drug delivery and molecular diagnosis. Biomol Eng 2006;23(4):171-84 (Pubitemid 44142336)
6. Hobbs SK, Monsky WL, Yuan F, et al. Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 1998;95(8):4607-12 (Pubitemid 28207960)
7. Yih TC, Al-Fandi M. Engineered nanoparticles as precise drug delivery systems. J Cell Biochem 2006;97(6):1184-90
8. des Rieux A, Fievez V, Garinot M, et al. Nanoparticles as potential oral delivery systems of proteins and vaccines: a mechanistic approach. J Control Release 2006;116(1):1-27 (Pubitemid 44792295)
9. Chaudhury A, Das S. Recent advancement of chitosan-based nanoparticles for oral controlled delivery of insulin and other therapeutic agents. AAPS PharmSciTech 2011;12(1):10-20
10. Makhlof A, Tozuka Y, Takeuchi H. Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery. Eur J Pharm Sci 2011;42(5):445-51
11. Grabovac V, Guggi D, Bernkop-Schnurch A. Comparison of the mucoadhesive properties of various polymers. Adv Drug Deliv Rev 2005;57(11):1713-23 (Pubitemid 41443475)
12. Hornof MD, Bernkop-Schnurch A. In vitro evaluation of the permeation enhancing effect of polycarbophil-cysteine conjugates on the cornea of rabbits. J Pharm Sci 2002;91(12):2588-92 (Pubitemid 35385624)
13. Kast CE, Guggi D, Langoth N, Bernkop-Schnurch A. Development and in vivo evaluation of an oral delivery system for low molecular weight heparin based on thiolated polycarbophil. Pharm Res 2003;20(6):931-6 (Pubitemid 36628442)
14. Takeuchi H, Yamamoto H, Kawashima Y. Mucoadhesive nanoparticulate systems for peptide drug delivery. Adv Drug Deliv Rev 2001;47(1):39-54 (Pubitemid 32209231)
15. Werle M, Hoffer M. Glutathione and thiolated chitosan inhibit multidrug resistance P-glycoprotein activity in excised small intestine. J Control Release 2006;111(1-2):41-6 (Pubitemid 43289993)
16. Foger F, Schmitz T, Bernkop-Schnurch A. In vivo evaluation of an oral delivery system for P-gp substrates based on thiolated chitosan. Biomaterials 2006;27(23):4250-5
17. Albrecht K, Bernkop-Schnurch A. Thiomers: forms, functions and applications to nanomedicine. Nanomedicine (Lond) 2007;2(1):41-50 (Pubitemid 46845775)
18. Bernkop-Schnurch A, Hornof M, Zoidl T. Thiolated polymers-thiomers: synthesis and in vitro evaluation of chitosan-2-iminothiolane conjugates. Int J Pharm 2003;260(2):229-37 (Pubitemid 36773920)
19. Kafedjiiski K, Krauland AH, Hoffer MH, Bernkop-Schnurch A. Synthesis and in vitro evaluation of a novel thiolated chitosan. Biomaterials 2005;26(7):819-26 (Pubitemid 39179966)
20. Millotti G, Samberger C, Frohlich E, Bernkop-Schnurch A. Chitosan-graft-6-mercaptonicotinic acid: synthesis, characterization, and biocompatibility. Biomacromolecules 2009;10(11):3023-7
21. Bernkop-Schnurch A, Hoffer MH, Kafedjiiski K. Thiomers for oral delivery of hydrophilic macromolecular drugs. Expert Opin Drug Deliv 2004;1(1):87-98 (Pubitemid 40297958)
22. Rahmat D, Sakloetsakun D, Shahnaz G, et al. Design and synthesis of a novel cationic thiolated polymer. Int J Pharm 2011;411(1-2):10-17
23. Bernkop-Schnurch A. Thiomers: a new generation of mucoadhesive polymers. Adv Drug Deliv Rev 2005;57(11):1569-82 (Pubitemid 41443470)
24. Bernkop-Schnurch A, Schwarz V, Steininger S. Polymers with thiol groups: a new generation of mucoadhesive polymers? Pharm Res 1999;16(6):876-81 (Pubitemid 29284199)
25. Bernkop-Schnurch A, Clausen AE, Hnatyszyn M. Thiolated polymers: synthesis and in vitro evaluation of polymer-cysteamine conjugates. Int J Pharm 2001;226(1-2):185-94 (Pubitemid 32800793)
26. Bernkop-Schnurch A, Leitner V, Moser V. Synthesis and in vitro characterization of a poly(acrylic acid)-homocysteine conjugate. Drug Dev Ind Pharm 2004;30(1):1-8 (Pubitemid 38240470)
27. Bernkop-Schnurch A, Kast CE, Richter MF. Improvement in the mucoadhesive properties of alginate by the covalent attachment of cysteine. J Control Release 2001;71(3):277-85 (Pubitemid 32276047)
28. Bernkop-Schnurch A, Steininger S. Synthesis and characterisation of mucoadhesive thiolated polymers. Int J Pharm 2000;194(2):239-47 (Pubitemid 30110686)
29. Majzoob S, Atyabi F, Dorkoosh F, et al. Pectin-cysteine conjugate: synthesis and in-vitro evaluation of its potential for drug delivery. J Pharm Pharmacol 2006;58(12):1601-10 (Pubitemid 46051675)
30. Jindal AB, Wasnik MN, Nair HA. Synthesis of thiolated alginate and evaluation of mucoadhesiveness, cytotoxicity and release retardant properties. Indian J Pharm Sci 2010;72(6):766-74
31. Davidovich-Pinhas M, Harari O, Bianco-Peled H. Evaluating the mucoadhesive properties of drug delivery systems based on hydrated thiolated alginate. J Control Release 2009;136(1):38-44
32. Sharma R, Ahuja M, Kaur H. Thiolated pectin nanoparticles: preparation, characterization and ex vivo corneal permeation study. Carbohydr Polym 2011;87:1606-10
33. Brandt J, Svenson A, Carlsson J, Drevin H. Covalent coupling of unsaturated compounds to thiol agrarose using gamma-Radiation. A new method for preparation of adsorbents for affinity chromatography. Appl Biochem Biotechnol 1977(2):2:109
34. Marschutz MK, Bernkop-Schnurch A. Thiolated polymers: self-crosslinking properties of thiolated 450 kDa poly(acrylic acid) and their influence on mucoadhesion. Eur J Pharm Sci 2002;15(4):387-94 (Pubitemid 34436926)
35. Burner U, Jantschko W, Obinger C. Kinetics of oxidation of aliphatic and aromatic thiols by myeloperoxidase compounds I and II. FEBS Lett 1999;443(3):290-6 (Pubitemid 29080813)
36. Mueller Christiane, Verroken Andrea, Iqbal Javed, Bernkop-Schnuerch Andreas. Journal of Applied Polymer Science, 2012; 124(6):5046-5055
37. Millotti G, Samberger C, Frohlich E, et al. Chitosan-4-mercaptobenzoic acid: synthesis and characterization of a novel thiolated chitosan. J Mater Chem 2010;20(12):2432-40
38. Perera G, Hombach J, Bernkop-Schnurch A. Hydrophobic thiolation of pectin with 4-aminothiophenol: synthesis and in vitro characterization. AAPS PharmSciTech 2010;11(1):174-80
39. Carlsson J, Drevin H, Axen R. Protein thiolation and reversible protein-protein conjugation. N-Succinimidyl 3-(2-pyridyldithio)propionate, a new heterobifunctional reagent. Biochem J 1978;173(3):723-37 (Pubitemid 9010965)
40. Norris R, Brocklehurst K. A convenient method of preparation of high-activity urease from Canavalia ensiformis by covalent chromatography and an investigation of its thiol groups with 2, 2¢-dipyridyl disulphide as a thiol titrant and reactivity probe. Biochem J 1976;159(2):245-57
41. Iqbal J, Shahnaz G, Dunnhaupt S, et al. Preactivated thiomers as mucoadhesive polymers for drug delivery. Biomaterials 2012;33(5):1528-35
42. Forrest HS, Fuller AT, Walker J. Chemotherapeutic agents of the sulphone type; effect of homologation on the antibacterial activity of p-methylsulphonyl-benzamidine and p-methylsulphonyl-benzylamine hydrochlorides. J Chem Soc 1948;3:1501-6
43. Dunnhaupt S, Barthelmes J, Rahmat D, et al. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties. Mol Pharm 2012;9(5):1331-41
44. Smart JD. The basics and underlying mechanisms of mucoadhesion. Adv Drug Deliv Rev 2005;57(11):1556-68 (Pubitemid 41443469)
45. Bernkop-Schnurch A, Hornof M, Guggi D. Thiolated chitosans. Eur J Pharm Biopharm 2004;57(1):9-17 (Pubitemid 38058800)
46. Kast CE, Bernkop-Schnurch A. Thiolated polymers-thiomers: development and in vitro evaluation of chitosan-thioglycolic acid conjugates. Biomaterials 2001;22(17):2345-52 (Pubitemid 32666227)
47. Hombach J, Bernkop-Schnurch A. Mucoadhesive drug delivery systems. Handb Exp Pharmacol 2010(197):251-66
48. Dunnhaupt S, Barthelmes J, Hombach J, et al. Distribution of thiolated mucoadhesive nanoparticles on intestinal mucosa. Int J Pharm 2011;408(1-2):191-9
49. Barthelmes J, Perera G, Hombach J, et al. Development of a mucoadhesive nanoparticulate drug delivery system for a targeted drug release in the bladder. Int J Pharm 2011;416(1):339-45
50. Barthelmes J, Dunnhaupt S, Unterhofer S, et al. Thiolated particles as effective intravestical drug delivery system for treatment of bladder related diseases. 2012;Under revision
51. Aungst BJ. Absorption enhancers: applications and advances. The AAPS Journal 2012;14(1):10-18
52. Luessen HL, de Leeuw BJ, Langemeyer MW, et al. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm Res 1996;13(11):1668-72 (Pubitemid 26426890)
53. Werle M, Kafedjiiski K, Kolmar H, Bernkop-Schnurch A. Evaluation and improvement of the properties of the novel cystine-knot microprotein McoEeTI for oral administration. Int J Pharm 2007;332(1-2):72-9 (Pubitemid 46227767)
54. Bernkop-Schnurch A, Guggi D, Pinter Y. Thiolated chitosans: development and in vitro evaluation of a mucoadhesive, permeation enhancing oral drug delivery system. J Control Release 2004;94(1):177-86 (Pubitemid 37542387)
55. Clausen AE, Kast CE, Bernkop-Schnurch A. The role of glutathione in the permeation enhancing effect of thiolated polymers. Pharm Res 2002;19(5):602-8 (Pubitemid 34553666)
56. Grafstrom R, Stead AH, Orrenius S. Metabolism of extracellular glutathione in rat small-intestinal mucosa. Eur J Biochem 1980;106(2):571-7 (Pubitemid 10025785)
57. Staddon JM, Herrenknecht K, Smales C, Rubin LL. Evidence that tyrosine phosphorylation may increase tight junction permeability. J Cell Sci 1995;108(Pt 2):609-19
58. Wang X, Iqbal J, Rahmat D, Bernkop-Schnurch A. Preaktivated thiomers: permeation enhancing properties. In preparation
59. Silverman JA. Multidrug-resistance transporters. Pharm Biotechnol 1999;12:353-86
60. Varma MV, Ashokraj Y, Dey CS, Panchagnula R. P-glycoprotein inhibitors and their screening: a perspective from bioavailability enhancement. Pharmacol Res 2003;48(4):347-59 (Pubitemid 36945333)
61. Dunnhaupt S, Barthelmes J, Rahmat D, et al. S-protected thiolated chitosan for oral delivery of hydrophilic macromolecules: evaluation of permeation enhancing and efflux pump inhibitory properties. Mol Pharmaceutics 2012;9(5):pp 1331-1341
62. Amidi M, Mastrobattista E, Jiskoot W, Hennink WE. Chitosan-based delivery systems for protein therapeutics and antigens. Adv Drug Deliv Rev 2010;62(1):59-82
63. Millotti G, Perera G, Vigl C, et al. The use of chitosan-6- mercaptonicotinic acid nanoparticles for oral peptide drug delivery. Drug Deliv 2011;18(3):190-7
64. Sakloetsakun D, Perera G, Hombach J, et al. The impact of vehicles on the mucoadhesive properties of orally administrated nanoparticles: a case study with chitosan-4-thiobutylamidine conjugate. AAPS PharmSciTech 2010;11(3):1185-92
65. Bernkop-Schnurch A, Heinrich A, Greimel A. Development of a novel method for the preparation of submicron particles based on thiolated chitosan. Eur J Pharm Biopharm 2006;63(2):166-72 (Pubitemid 43776219)
66. Barthelmes J, Dunnhaupt S, Hombach J, Bernkop-Schnurch A. Thiomer nanoparticles: stabilization via covalent cross-linking. Drug Deliv 2011;18(8):613-19
67. Thaurer MH, Deutel B, Schlocker W, Bernkop-Schnurch A. Development of nanoparticulate drug delivery systems based on thiolated poly(acrylic acid). J Microencapsul 2009;26(3):187-94
68. Bravo-Osuna I, Schmitz T, Bernkop-Schnurch A, et al. Elaboration and characterization of thiolated chitosan-coated acrylic nanoparticles. Int J Pharm 2006;316(1-2):170-5 (Pubitemid 43765693)
69. Mazzaferro S, Bouchemal K, Vauthier C, et al. What are parameters affecting Leu-enkephalin loading and release from poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan? J Drug Deliv Sci Technol 2011;21(5):385-93
70. Nagpal K, Singh SK, Mishra DN. Chitosan nanoparticles: a promising system in novel drug delivery. Chem Pharm Bull (Tokyo) 2010;58(11):1423-30
71. Saboktakin MR, Tabatabaie RM, Maharramov A, Ramazanov MA. Synthesis and in vitro evaluation of thiolated chitosan-dextran sulfate nanoparticles for the delivery of letrozole. 2010;1(2):62-7
72. Agnihotri SA, Mallikarjuna NN, Aminabhavi TM. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J Control Release 2004;100(1):5-28 (Pubitemid 39445982)
73. Lee D, Zhang W, Shirley SA, et al. Thiolated chitosan/DNA nanocomplexes exhibit enhanced and sustained gene delivery. Pharm Res 2007;24(1):157-67 (Pubitemid 44902580)
74. Yin L, Ding J, He C, et al. Drug permeability and mucoadhesion properties of thiolated trimethyl chitosan nanoparticles in oral insulin delivery. Biomaterials 2009;30(29):5691-700
75. Perera G, Greindl M, Palmberger TF, Bernkop-Schnurch A. Insulin-loaded poly (acrylic acid)-cysteine nanoparticles: stability studies towards digestive enzymes of the intestine. Drug Deliv 2009;16(5):254-60
76. Bouchemal K, Ponchell G, Mazzaferro S, et al. A new approach to determine loading efficiency of Leu-enkephalin in poly(isobutylcyanoacrylate) nanoparticles coated with thiolated chitosan. J Drug Deliv Sci Technol 2008;18(6):392-7
77. Requena V, Bouchemal K, Vauthier C, Ponchel G. Encapsulation of leu-enkephalin in core-shell isobutylcyanoacrylate-thiolated chitosan nanoparticles for oral administratton. J Chilean Chem Soc 2008;53(4):1677-81
78. Shahnaz G, Vetter A, Barthelmes J, et al. Thiolated chitosan nanoparticles for the nasal administration of leuprolide: bioavailability and pharmacokinetic characterization. Int J Pharm 2012;428(1-2):164-70
79. Makhlof A, Werle M, Tozuka Y, Takeuchi H. Nanoparticles of glycol chitosan and its thiolated derivative significantly improved the pulmonary delivery of calcitonin. Int J Pharm 2010;397(1-2):92-5
80. Carlisle RC, Etrych T, Briggs SS, et al. Polymer-coated polyethylenimine/DNA complexes designed for triggered activation by intracellular reduction. J Gene Med 2004;6(3):337-44 (Pubitemid 40228051)
81. Kommareddy S, Amiji M. Preparation and evaluation of thiol-modified gelatin nanoparticles for intracellular DNA delivery in response to glutathione. Bioconjug Chem 2005;16(6):1423-32 (Pubitemid 41681508)
82. Mao HQ, Roy K, Troung-Le VL, et al. Chitosan-DNA nanoparticles as gene carriers: synthesis, characterization and transfection efficiency. J Control Release 2001;70(3):399-421 (Pubitemid 32155463)
83. Talaei F, Azizi E, Dinarvand R, Atyabi F. Thiolated chitosan nanoparticles as a delivery system for antisense therapy: evaluation against EGFR in T47D breast cancer cells. Int J Nanomedicine 2011;6:1963-75
84. Martien R, Loretz B, Thaler M, et al. Chitosan-thioglycolic acid conjugate: an alternative carrier for oral nonviral gene delivery? J Biomed Mater Res A 2007;82(1):1-9 (Pubitemid 46906486)
85. Counis MF, Torriglia A. DNases and apoptosis. Biochem Cell Biol 2000;78(4):405-14
86. Schmitz T, Bravo-Osuna I, Vauthier C, et al. Development and in vitro evaluation of a thiomer-based nanoparticulate gene delivery system. Biomaterials 2007;28(3):524-31 (Pubitemid 44602224)
87. Loretz B, Thaler M, Bernkop-Schnurch A. Role of sulfhydryl groups in transfection? A case study with chitosan-NAC nanoparticles. Bioconjug Chem 2007;18(4):1028-35 (Pubitemid 47122622)